Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA073017-01
Application #
2115728
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1996-07-01
Project End
1999-06-30
Budget Start
1996-07-01
Budget End
1997-06-30
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Surgery
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Li, Yingming; Okegawa, Takatsugu; Lombardi, Donald P et al. (2002) Enhanced transgene expression in androgen independent prostate cancer gene therapy by taxane chemotherapeutic agents. J Urol 167:339-46
Okegawa, T; Li, Y; Pong, R C et al. (2000) The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. Cancer Res 60:5031-6
Hall, M C; Li, Y; Pong, R C et al. (2000) The growth inhibitory effect of p21 adenovirus on human bladder cancer cells. J Urol 163:1033-8
Chen, Y Q; Hsieh, J T; Yao, F et al. (1999) Induction of apoptosis and G2/M cell cycle arrest by DCC. Oncogene 18:2747-54
Li, Y; Pong, R C; Bergelson, J M et al. (1999) Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res 59:325-30